中文
Announcement
More
Progress in Chemistry 2013, Vol. 25 Issue (09): 1421-1428 DOI: 10.7536/PC130409 Previous Articles   Next Articles

A Mini-Review of Chemoprevention of Cancer——Past, Present, and Future

Michael B. Sporn*, Karen T. Liby   

  1. Department of Pharmacology, Geisel School of Medicine at Dartmouth, Hanover, New Hampshire 03755, USA
  • Received: Online: Published:
  • Contact: Michael B. Sporn E-mail:michael.b.sporn@dartmouth.edu
Richhtml ( 3 ) PDF ( 962 ) Cited
Export

EndNote

Ris

BibTeX

We present a brief review of the history of chemoprevention of cancer, the present status of this field, and its prospects for the future. Topics covered are the scientific basis for chemoprevention of cancer, drugs in current use for chemoprevention of cancer, the need for new synthetic drugs, and the challenges ahead. The importance of the use of combinations of drugs for effective prevention is stressed.

CLC Number: 

[1] Bishop J M. Science, 1997, 278: 995
[2] Davidson N, Kensler T W. N. Engl. J. Med., 2011, 365: 2463—2464
[3] Sporn M B, Dunlop N M, Newton D L, Smith J M. Fed. Proc., 1976, 35: 1332—1338
[4] Sporn M B. Cancer Res., 1976, 36: 2699—2702
[5] Sporn M B. Lancet, 1996, 347: 1377—1381
[6] Sporn M B, Suh N. Nat. Rev. Cancer, 2002, 2: 537—543
[7] Sporn M B, Liby K T. Nat. Clin. Pract. Oncol., 2005, 2: 518—525
[8] Sporn M B. Nat. Clin. Pract. Oncol., 2006, 3: 364—373
[9] Albini A, Sporn M B. Nat. Rev. Cancer, 2007, 7: 139—147
[10] Liby K T, Yore M M, Sporn M B. Nat. Rev. Cancer, 2007, 7: 357—369
[11] Sporn M B. Nature, 2011, 471: S10—S11
[12] O'Shaughnessy J A, Kelloff G J, Gordon G B, Dannenberg A J, Hong W K, Fabian C J, Sigman C C, Bertagnolli M M, Stratton S P, Lam S, Nelson W G, Meyskens F L, Alberts D S, Follen M, Rustgi A K, Papadimitrakopoulou V, Scardino P T, Gazdar A F, Wattenberg L W, Sporn M B, Sakr W A, Lippman S M, von Hoff D D. Clin. Cancer Res., 2002, 8: 314—346
[13] Sporn M B. Cancer Res., 1991, 51: 6215—6218
[14] Hruban R H, Goggins M, Parsons J, Kern S E. Clin. Cancer Res., 2000, 6: 2969—2972
[15] Hingorani S R, Wang L, Multani A S, Combs C, Deramaudt T B, Hruban R H, Rustgi A K, Chang S, Tuveson D A. Cancer Cell, 2005, 7: 469—483
[16] Hingorani S R, Petricoin E F, Maitra A, Rajapakse V, King C, Jacobetz M A, Ross S, Conrads T P, Veenstra T D, Hitt B A, Kawaguchi Y, Johann D, Liotta L A, Crawford H C, Putt M E, Jacks T, Wright C V, Hruban R H, Lowy A M, Tuveson D A. Cancer Cell, 2003, 4: 437—450
[17] Pleasance E D, Stephens P J, O'Meara S, McBride D J, Meynert A, Jones D, Lin M L, Beare D, Lau K W, Greenman C, Varela I, Nik-Zainal S, Davies H R, Ordoñez G R, Mudie L J, Latimer C, Edkins S, Stebbings L, Chen L, Jia M, Leroy C, Marshall J, Menzies A, Butler A, Teague J W, Mangion J, Sun Y A, McLaughlin S F, Peckham H E, Tsung E F, Costa G L, Lee C C, Minna J D, Gazdar A, Birney E, Rhodes M D, McKernan K J, Stratton M R, Futreal P A, Campbell P J. Nature, 2010, 463: 184—190
[18] Sporn M B. Nature, 1980, 287: 107—108
[19] Meyskens F L Jr, McLaren C E, Pelot D, Fujikawa-Brooks S, Carpenter P M, Hawk E, Kelloff G, Lawson M J, Kidao J, McCracken J, Albers C G, Ahnen D J, Turgeon D K, Goldschmid S, Lance P, Hagedorn C H, Gillen D L, Gerner E W. Cancer Prev. Res., 2008, 1: 32—38
[20] Rendi M H, Suh N, Lamph W W, Krajewski S, Reed J C, Heyman R A, Berchuck A, Liby K, Risingsong R, Royce D B, Williams C R, Sporn M B. Cancer Res., 2004, 64: 3566—3571
[21] Tran K, Risingsong R, Royce D B, Williams C R, Sporn M B,Pioli P A, Gediya L K, Njar V C, Liby K T. Carcinogenesis, 2013, 34: 199—210
[22] Solomon S D, McMurray J J, Pfeffer M A, Wittes J, Fowler R, Finn P, Anderson W F, Zauber A, Hawk E, Bertagnolli M. N. Engl. J. Med., 2005, 352: 1071—1080
[23] Bresalier R S, Sandler R S, Quan H, Bolognese J A, Oxenius B, Horgan K, Lines C, Riddell R, Morton D, Lanas A, Konstam M A, Baron J A. N. Engl. J. Med., 2005, 352: 1092—1102
[24] Wu X, Lippman S M. Nat. Rev. Cancer, 2011, 11: 879—885
[25] LaCroix A Z, Powles T, Osborne C K, Wolter K, Thompson J R, Thompson D D, Allred D C, Armstrong R, Cummings S R, Eastell R, Ensrud K E, Goss P, Lee A, Neven P, Reid D M, Curto M, Vukicevic S. J. Natl. Cancer Inst., 2010, 102: 1706—1715
[26] Andriole G L, Bostwick D G, Brawley O W, Gomella L G, Marberger M, Montorsi F, Pettaway C A, Tammela T L, Teloken C, Tindall D J, Somerville M C, Wilson T H, Fowler I L, Rittmaster R S. N. Engl. J. Med., 2010, 362: 1192—1202
[27] Chan A T. Prog. Chem., 2013, 25: 1450—1453
[28] Decensi A, Puntoni M, Goodwin P, Cazzaniga M, Gennari A, Bonanni B, Gandini S. Cancer Prev. Res. (Phila), 2010, 3: 1451—1461
[29] Umar A, Dunn B K, Greenwald P. Nature Reviews Cancer, 2012, 12: 835—848
[30] Egner P A, Wang J B, Kensler T W, et al. Prog. Chem., 2013, 25: 1454—1461
[31] Sporn M B, Liby K T, Yore M M, Suh N, Albini A, Honda T, Sundararajan C, Gribble G W. Drug Dev. Res., 2007, 68: 174—182
[32] Sporn M B, Liby K T, Yore M M, Fu L, Lopchuk J M, Gribble G W. J. Nat. Prod., 2011, 74: 537—545
[33] Liby K T, Sporn M B. Pharmacol. Revs., 2012, 64: 972—1003
[34] Liby K, Royce D B, Williams C R, Risingsong R, Yore M M, Honda T, Gribble G W, Dmitrovsky E, Sporn T A, Sporn M B. Cancer Res., 2007, 67: 2414—2419
[35] Yore M M, Kettenbach A N, Sporn M B, Gerber S A, Liby K T. PLoS One, 2011, 6: 22862—22863
[36] Hong D S, Kurzrock R, Supko J G, He X, Naing A, Wheler J, Lawrence D, Eder J P, Meyer C J, Ferguson D A, Mier J, Konopleva M, Konoplev S, Andreeff M, Kufe D, Lazarus H, Shapiro G I, Dezube B J. Clin. Cancer Res., 2012, 18: 3396—3406
[37] Foulds L. Neoplastic Development. London ; New York: Academic P. 1969. 269
[38] Clark W H Jr. Acta Oncol., 1995, 34: 3—21
[39] Bissell M J, Hines W C. Nat. Med., 2011, 17: 320—329
[40] Coussens L M, Zitvogel L, Palucka A K. Science, 2013, 339: 286—291
[41] Albini A, Tosetti F, Li V W, Noonan D M, Li W W. Nat. Rev. Clin. Oncol., 2012, 9: 498—509
[42] Dawson M A, Kouzarides T. Cell, 2012, 150: 12—27
[43] Huang Y W, Kuo C T, Stoner K, Huang T H, Wang L S. FEBS Lett., 2011, 585: 2129—2136
[44] Lee J H, Khor T O, Shu L, Su Z Y, Fuentes F, Kong A N. Pharmacol. Ther., 2013, 137(2): 153—171
[45] Guttman M, Amit I, Garber M, French C, Lin M F, Feldser D, Huarte M, Zuk O, Carey B W, Cassady J P, Cabili M N, Jaenisch R, Mikkelsen T S, Jacks T, Hacohen N, Bernstein B E, Kellis M, Regev A, Rinn J L, Lander E S. Nature, 2009, 458: 223—227
[46] Lee J T. Science, 2012, 338: 1435—1439
[47] You J S, Jones P A. Cancer Cell, 2012, 22: 9—20
[48] Tsai H C, Baylin S B. Cell Res., 2011, 21: 502—517
[49] Gerlinger M, Rowan A J, Horswell S, Larkin J, Endesfelder D, Gronroos E, Martinez P, Matthews N, Stewart A, Tarpey P, Varela I, Phillimore B, Begum S, McDonald N Q, Butler A, Jones D, Raine K, Latimer C, Santos C R, Nohadani M, Eklund A C, Spencer-Dene B, Clark G, Pickering L, Stamp G, Gore M, Szallasi Z, Downward J, Futreal P A, Swanton C. N. Engl. J. Med., 2012, 366: 883—892
[50] Swanton C. Cancer Res., 2012, 72: 4875—4882
[51] Longo D L. N. Engl. J. Med., 2012, 366: 956—957
[52] Hopkins A L. Nat. Biotechnol., 2007, 25: 1110—1111
[53] Barabasi A L. Linked: How Everything is Connected to Everything Else and What it Means. New York: Penguin Group, 2000
[54] Prevention of Cancer in the Next Millennium: Report of the Chemoprevention Working Group to the American Association for Cancer Research. Cancer Res., 1999, 59: 4743—4758
[55] Levy E D, Landry C R, Michnick S W. Science, 2010, 328: 983—984

[1] Dang Zhang, Xi Wang, Lei Wang. Biomedical Applications of Enzyme-Powered Micro/Nanomotors [J]. Progress in Chemistry, 2022, 34(9): 2035-2050.
[2] Xiaodong Jing, Ying Sun, Bing Yu, Youqing Shen, Hao Hu, Hailin Cong. Rational Design of Tumor Microenvironment Responsive Drug Delivery Systems [J]. Progress in Chemistry, 2021, 33(6): 926-941.
[3] Jiajia Wang, Huiying Wu, Renfeng Dong, Yuepeng Cai. Micro/Nanomotors on the Way to Intelligent Cancer Diagnosis, Delivery and Therapy [J]. Progress in Chemistry, 2021, 33(5): 883-894.
[4] Yunxue Wu, Hengyi Zhang, Yu Liu. Application of Azobenzene Derivative Probes in Hypoxia Cell Imaging [J]. Progress in Chemistry, 2021, 33(3): 331-340.
[5] Shan Guo, Xiang Zhou. Detection of Circulating Tumor Cell in Vivo:Technology and Application [J]. Progress in Chemistry, 2021, 33(1): 1-12.
[6] Ziru Sun, Shengnan Liu, Qingzhi Gao. Development of Anticancer Drugs Targeting Glucose Transporters(GLUTs) [J]. Progress in Chemistry, 2020, 32(12): 1869-1878.
[7] Xinyi Lai, Zhiyong Wang, Yongtai Zheng, Yongming Chen. Nanoscale Metal Organic Frameworks for Drug Delivery [J]. Progress in Chemistry, 2019, 31(6): 783-790.
[8] Bingde Zheng, Yuanyuan Zhao, Hongcai Li, Biyuan Zheng, Meirong Ke, Jiandong Huang*. Activatable Photodynamic Anticancer Photosensitizers [J]. Progress in Chemistry, 2018, 30(9): 1403-1414.
[9] Liang He, Caiping Tan, Qian Cao, Zongwan Mao. Application of Phosphorescent Cyclometalated Iridium(Ⅲ) Complexes in Cancer Treatment [J]. Progress in Chemistry, 2018, 30(10): 1548-1556.
[10] Juan Shen, Yang Zhu, Hongdong Shi, Yangzhong Liu. Multifunctional Nanodrug Delivery Systems for Platinum-Based Anticancer Drugs [J]. Progress in Chemistry, 2018, 30(10): 1557-1572.
[11] Gong Zhaocui, Yin Chao, Zhao Hui, Lu Xiaomei, Fan Quli, Huang Wei. Light-Controlled Nanocarriers for Drug Release [J]. Progress in Chemistry, 2016, 28(9): 1387-1396.
[12] Jiang Ge, Luo Feng, Xu Yaozhong, Zhang Xiaohui. UVA Assisted 4-Thiothymidine for Cancer Treatment [J]. Progress in Chemistry, 2016, 28(8): 1224-1237.
[13] Zheng Xiaohui, Xia Lixin, Mao Zongwan. The New Anticancer Platinum Complex Designed on the Basis of Nucleic Acid [J]. Progress in Chemistry, 2016, 28(7): 1029-1038.
[14] Ye Jiqing, Yue Xiaohong, Sun Liping. Small Molecule Inhibitors of IL-6/STAT3 Signaling [J]. Progress in Chemistry, 2016, 28(7): 1099-1111.
[15] Huang Di, Xiang Nan, Tang Wenlai, Zhang Xinjie, Ni Zhonghua. Microfluidics-Based Circulating Tumor Cells Separation [J]. Progress in Chemistry, 2015, 27(7): 882-912.